Sector 10, Inc. (SECI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 39.84 Thousand USD | 15.23% |
| 2022 | 34.57 Thousand USD | 20.92% |
| 2021 | 28.59 Thousand USD | -96.56% |
| 2020 | 832.1 Thousand USD | 0.01% |
| 2019 | 832.02 Thousand USD | 3.93% |
| 2018 | 800.57 Thousand USD | -6.34% |
| 2017 | 854.78 Thousand USD | 3.18% |
| 2016 | 828.44 Thousand USD | 1.55% |
| 2015 | 815.83 Thousand USD | 5.78% |
| 2014 | 771.26 Thousand USD | -3.32% |
| 2013 | 797.75 Thousand USD | -0.81% |
| 2012 | 804.27 Thousand USD | -56.59% |
| 2011 | 1.85 Million USD | -57.11% |
| 2010 | 4.31 Million USD | 320.39% |
| 2009 | 1.02 Million USD | 755.32% |
| 2008 | 120.13 Thousand USD | -87.12% |
| 2007 | 932.93 Thousand USD | 160.89% |
| 2006 | 357.59 Thousand USD | 12.4% |
| 2005 | 318.15 Thousand USD | 31.28% |
| 2004 | 242.35 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 3400.00 USD | 105.07% |
| 2024 Q2 | 1658.00 USD | 223.83% |
| 2024 Q1 | 512.00 USD | -98.47% |
| 2023 Q2 | 3008.00 USD | 82.86% |
| 2023 Q3 | 1658.00 USD | -44.88% |
| 2023 Q4 | 33.53 Thousand USD | 1922.5% |
| 2023 FY | 39.84 Thousand USD | 15.23% |
| 2023 Q1 | 1645.00 USD | -78.61% |
| 2022 Q4 | 7692.00 USD | 6.77% |
| 2022 Q1 | 11.18 Thousand USD | 297.74% |
| 2022 Q2 | 8498.00 USD | -24.02% |
| 2022 FY | 34.57 Thousand USD | 20.92% |
| 2022 Q3 | 7204.00 USD | -15.23% |
| 2021 FY | 28.59 Thousand USD | -96.56% |
| 2021 Q1 | 204.62 Thousand USD | -11.38% |
| 2021 Q2 | 176.95 Thousand USD | -13.53% |
| 2021 Q3 | 6575.00 USD | -96.28% |
| 2021 Q4 | -5656.00 USD | -186.02% |
| 2020 Q1 | 207.91 Thousand USD | -0.33% |
| 2020 Q4 | 230.89 Thousand USD | 16.37% |
| 2020 Q3 | 198.42 Thousand USD | 1.82% |
| 2020 FY | 832.1 Thousand USD | 0.01% |
| 2020 Q2 | 194.87 Thousand USD | -6.27% |
| 2019 Q1 | 205.98 Thousand USD | 0.13% |
| 2019 FY | 832.02 Thousand USD | 3.93% |
| 2019 Q4 | 208.61 Thousand USD | 0.29% |
| 2019 Q3 | 208 Thousand USD | -0.67% |
| 2019 Q2 | 209.41 Thousand USD | 1.67% |
| 2018 Q1 | 197.82 Thousand USD | -4.84% |
| 2018 FY | 800.57 Thousand USD | -6.34% |
| 2018 Q4 | 205.72 Thousand USD | 3.99% |
| 2018 Q3 | 197.82 Thousand USD | -0.7% |
| 2018 Q2 | 199.21 Thousand USD | 0.71% |
| 2017 Q1 | 188.5 Thousand USD | -9.69% |
| 2017 FY | 854.78 Thousand USD | 3.18% |
| 2017 Q4 | 207.89 Thousand USD | -13.38% |
| 2017 Q3 | 240 Thousand USD | 9.89% |
| 2017 Q2 | 218.39 Thousand USD | 15.86% |
| 2016 FY | 828.44 Thousand USD | 1.55% |
| 2016 Q3 | 205.54 Thousand USD | -1.37% |
| 2016 Q2 | 208.39 Thousand USD | 1.28% |
| 2016 Q4 | 208.73 Thousand USD | 1.55% |
| 2016 Q1 | 205.76 Thousand USD | -1.84% |
| 2015 Q4 | 209.62 Thousand USD | 11.45% |
| 2015 Q2 | 210.01 Thousand USD | 0.92% |
| 2015 FY | 815.83 Thousand USD | 5.78% |
| 2015 Q1 | 208.09 Thousand USD | 3.85% |
| 2015 Q3 | 188.09 Thousand USD | -10.44% |
| 2014 Q1 | 193.46 Thousand USD | -7.64% |
| 2014 FY | 771.26 Thousand USD | -3.32% |
| 2014 Q2 | 182.36 Thousand USD | -5.74% |
| 2014 Q3 | 195.05 Thousand USD | 6.96% |
| 2014 Q4 | 200.38 Thousand USD | 2.73% |
| 2013 FY | 797.75 Thousand USD | -0.81% |
| 2013 Q4 | 209.45 Thousand USD | -7.85% |
| 2013 Q3 | 227.28 Thousand USD | 7.92% |
| 2013 Q2 | 210.61 Thousand USD | 40.04% |
| 2013 Q1 | 150.39 Thousand USD | -50.54% |
| 2012 Q1 | 212.5 Thousand USD | -88.53% |
| 2012 FY | 804.27 Thousand USD | -56.59% |
| 2012 Q4 | 304.1 Thousand USD | 121.35% |
| 2012 Q3 | 137.38 Thousand USD | -8.58% |
| 2012 Q2 | 150.28 Thousand USD | -29.28% |
| 2011 FY | 1.85 Million USD | -57.11% |
| 2011 Q4 | 1.85 Million USD | 3413.69% |
| 2011 Q3 | -55.91 Thousand USD | -110.9% |
| 2011 Q2 | 513.09 Thousand USD | 77.28% |
| 2011 Q1 | 289.42 Thousand USD | -90.9% |
| 2010 Q4 | 3.17 Million USD | 665.41% |
| 2010 FY | 4.31 Million USD | 320.39% |
| 2010 Q1 | 412.33 Thousand USD | -22.57% |
| 2010 Q2 | 312.2 Thousand USD | -24.28% |
| 2010 Q3 | 415.39 Thousand USD | 33.05% |
| 2009 Q2 | 132.82 Thousand USD | -82.46% |
| 2009 Q3 | 122.03 Thousand USD | -8.13% |
| 2009 FY | 1.02 Million USD | 755.32% |
| 2009 Q4 | 532.51 Thousand USD | 336.37% |
| 2009 Q1 | 757.33 Thousand USD | 1135.73% |
| 2008 Q1 | 325.62 Thousand USD | 159.68% |
| 2008 FY | 120.13 Thousand USD | -87.12% |
| 2008 Q4 | 61.28 Thousand USD | 4.15% |
| 2008 Q3 | 58.84 Thousand USD | -81.93% |
| 2008 Q2 | 325.62 Thousand USD | 0.0% |
| 2007 Q2 | 108.62 Thousand USD | -27.27% |
| 2007 Q4 | -545.61 Thousand USD | -144.6% |
| 2007 FY | 932.93 Thousand USD | 160.89% |
| 2007 Q1 | 149.35 Thousand USD | 103.74% |
| 2007 Q3 | 1.22 Million USD | 1026.16% |
| 2006 FY | 357.59 Thousand USD | 12.4% |
| 2006 Q4 | 73.3 Thousand USD | 10.01% |
| 2006 Q3 | 66.63 Thousand USD | -40.23% |
| 2006 Q2 | 111.49 Thousand USD | 165.17% |
| 2006 Q1 | -171.07 Thousand USD | -281.76% |
| 2005 Q2 | 87.16 Thousand USD | -6.83% |
| 2005 FY | 318.15 Thousand USD | 31.28% |
| 2005 Q1 | 93.55 Thousand USD | -61.03% |
| 2005 Q4 | 94.11 Thousand USD | 74.07% |
| 2005 Q3 | 54.07 Thousand USD | -37.96% |
| 2004 FY | 242.35 Thousand USD | 0.0% |
| 2004 Q4 | 240.07 Thousand USD | 270.38% |
| 2004 Q2 | 31.88 Thousand USD | 1301.41% |
| 2004 Q3 | -140.9 Thousand USD | -541.96% |
| 2004 Q1 | 2275.00 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | 98.608% |
| Ansell Limited | 495.5 Million USD | 99.992% |
| Ansell Limited | 495.5 Million USD | 99.992% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | 99.952% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | 97.698% |
| Psykey, Inc. | 1.21 Million USD | 96.717% |
| ConvaTec Group Plc | 910.31 Million USD | 99.996% |
| ConvaTec Group Plc | 872.5 Million USD | 99.995% |
| Encision Inc. | 3.77 Million USD | 98.945% |
| Golden Valley Development, Inc | 141.81 Thousand USD | 71.903% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | 63.755% |
| Innovative MedTech Inc. | 6.09 Million USD | 99.347% |
| LifePoint, Inc. | 7.42 Million USD | 99.463% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 99.372% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | 95.34% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | 94.513% |
| Reflect Scientific, Inc. | 1.06 Million USD | 96.254% |
| SmileDirectClub, Inc. | 517 Million USD | 99.992% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.999% |
| SheerVision, Inc. | 2.33 Million USD | 98.291% |
| United Health Products, Inc. | 2.42 Million USD | 98.358% |
| Vasamed, Inc. | 4.67 Million USD | 99.147% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | 98.445% |
| Yubo International Biotech Limited | 1.25 Million USD | 96.832% |